Overview

Medications for the Treatment of Dysthymic Disorder and Double Depression

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of flexible doses of escitalopram (Lexapro) compared to sertraline (Zoloft) for treatment of Dysthymic Disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
Forest Laboratories
Treatments:
Citalopram
Dexetimide
Sertraline